FAQ

Levocabastine hydrochloride

Known as: 4-Piperidinecarboxylic Acid, 1-(4-cyano-4-(4-fluorophenyl)cyclohexyl)-3-methyl-4-phenyl-, Monohydrochloride,(-)-(1(cis)3alpha,4beta)-, R 50,547 
The hydrochloride salt form of levocabastine, a synthetic piperidine derivative with antihistaminic properties. Levocabastine is a second generation… (More)
National Institutes of Health

Topic mentions per year

Topic mentions per year

1993-2017
01219932017

Related topics

Related topics

4 relations
Allergic ConjunctivitisHistamine H1 Receptor Antagonists [MoA]

Narrower (1)

Livostin

Broader (1)

levocabastine

Related mentions per year

Related mentions per year

1947-2018
19401960198020002020
Levocabastine hydrochloride
Allergic Conjunctivitis
levocabastine
Livostin
Histamine H1 Receptor Antagonists [MoA]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
2008
2008
Treatment of allergic conjunctivitis with olopatadine hydrochloride eye drops
Olopatadine hydrochloride exerts a wide range of pharmacological actions such as histamine H(1) receptor antagonist action… (More)
  • figure 1
Is this relevant?
2006
2006
Efficacy of levocabastine hydrochloride ophthalmic suspension in the conjunctival allergen challenge test in Japanese subjects with seasonal allergic conjunctivitis.
BACKGROUND This study was conducted to investigate the efficacy and safety of 0.025% levocabastine hydrochloride in Japanese… (More)
  • table 1
  • table 2
  • table 3
  • figure 1
  • figure 2
Is this relevant?
2005
2005
Efficacy, cost-effectiveness, and tolerability of mometasone furoate, levocabastine, and disodium cromoglycate nasal sprays in the treatment of seasonal allergic rhinitis.
BACKGROUND Current guidelines recommend intranasal glucocorticosteroids as first-line therapy for seasonal allergic rhinitis… (More)
Is this relevant?
2005
2005
Increasing effect by simultaneous use of levocabastine and pemirolast on experimental allergic conjunctivitis in rats.
The effect of the simultaneous use of 0.025% levocabastine hydrochloride eye drops (levocabastine) and 0.1% pemirolast potassium… (More)
Is this relevant?
2004
2004
Efficacy and tolerability of ophthalmic epinastine: a randomized, double-masked, parallel-group, active- and vehicle-controlled environmental trial in patients with seasonal allergic conjunctivitis.
BACKGROUND Epinastine hydrochloride is an antihistamine with mast cell-stabilizing and anti-inflammatory activity. OBJECTIVE… (More)
Is this relevant?
2003
2003
Efficacy and safety of ketotifen eye drops in the treatment of seasonal allergic conjunctivitis.
BACKGROUND Ketotifen blocks histamine H(1) receptors, stabilises mast cells, and prevents eosinophil accumulation. These multiple… (More)
  • table 2
  • table 1
  • figure 1
  • table 3
  • table 4
Is this relevant?
Review
2002
Review
2002
[Pharmacological and clinical properties of levocabastine hydrochloride (eye drop and nasal spray), a selective H1 antagonist].
Levocabastine is a selective histamine H1-receptor antagonist exerting inhibitory effects on the release of chemical mediators… (More)
Is this relevant?
2000
2000
An efficacy and tolerance comparison of emedastine difumarate 0.05% and levocabastine hydrochloride 0.05%: reducing chemosis and eyelid swelling in subjects with seasonal allergic conjunctivitis…
PURPOSE To compare emedastine ophthalmic solution 0.05% BID to levocabastine ophthalmic suspension 0.05% BID in reducing chemosis… (More)
Is this relevant?
2000
2000
Emedastine ophthalmic solution 0.05% versus levocabastine ophthalmic suspension 0.05% in the treatment of allergic conjunctivitis using the conjunctival allergen challenge model.
PURPOSE To compare a new ocular antihistamine, emedastine difumarate (Emadine Ophthalmic Solution 0.05%; Alcon Laboratories, Fort… (More)
Is this relevant?
1999
1999
Inhibition of histamine-induced human conjunctival epithelial cell responses by ocular allergy drugs.
OBJECTIVE To evaluate the effects of topical ocular drugs with histamine H1-antagonist activity on histamine-stimulated… (More)
Is this relevant?